Who Paid My Doc
M15-737 ABBV-951 Ph 3 Open Label Extension Study (Ind 1)
ClinicalTrials.gov NCT04379050
Research payments
$7,000
Through program year 2024, $7,000 in research payments was reported against M15-737 ABBV-951 Ph 3 Open Label Extension Study (Ind 1), across 12 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT04379050
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $7,000 | 12 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Arjun Tarakad Houston, TX Named on 1 payment
- Rajesh Pahwa Kansas City, KS Named on 1 payment
- Mwiza Ushe Saint Louis, MO Named on 1 payment
- Drew Kern Aurora, CO Named on 1 payment
- Stuart Isaacson Boca Raton, FL Named on 1 payment
- Jill Baird Vancouver, WA Named on 1 payment
- Jason Aldred Spokane, WA Named on 1 payment
- Sara Dhanani Sun City, AZ Named on 1 payment
- Elizabeth Peckham Round Rock, TX Named on 1 payment
- David Standaert Birmingham, AL Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.